Target intelligence / Profile preview

Protein kinase C delta (PKCδ) – Receptor for activated C kinase (RACK) interface (PKCδ-RACK interface)

Target
PKCδ-RACK interface
Molecular classification
Protein-protein interaction, Enzyme, Scaffolding protein
01

Overview

The Protein kinase C delta (PKCδ) – Receptor for activated C kinase (RACK) interface is a specialized protein-protein interaction site essential for the spatial regulation of PKCδ signaling (Mochly-Rosen et al., 2012, Nature Reviews Drug Discovery). PKCδ is a member of the novel PKC subfamily that plays a dual role in cell survival and apoptosis depending on its subcellular localization (Inagaki et al., 2003, Circulation). The interaction with RACK proteins facilitates the translocation of activated PKCδ to specific compartments like the mitochondria, where it can promote pro-apoptotic signaling during ischemia-reperfusion injury (Churchill et al., 2008, Annual Review of Pharmacology and Toxicology). Because the RACK-binding site is distinct for each PKC isoform, targeting this interface allows for the development of highly selective inhibitors, such as the peptide delcasertib (KAI-9803), which avoids the off-target effects common to ATP-competitive kinase inhibitors (Bates et al., 2008, Journal of the American College of Cardiology). This interface has been a major focus in cardiovascular research, particularly for reducing infarct size during myocardial infarction, and is also investigated in oncology and neuroprotection (Palaniyandi et al., 2009, Cardiovascular Research). Successful modulation of this interface prevents the detrimental effects of PKCδ activation while sparing the cytoprotective functions of other isoforms like PKCε.

Other names
PKC delta-RACK interactionPRKCD-RACK1 interfaceδV1-1 binding sitePKCδ-RACK complex
02

Mechanism of action

Inhibition of protein-protein interaction to prevent isoform-specific translocation of Protein kinase C delta to its functional sites.

03

Biological functions

Signal transductionApoptosisMitochondrial regulationCellular translocation
04

Disease associations

Myocardial infarctionIschemia-reperfusion injuryHeart failureCancerDiabetes
05

Safety considerations

Peptide delivery and stabilityIsoform selectivityShort half-life of peptide mimetics
06

Interacting drugs

Delcasertib

2 more in the full profile.

07

Biomarkers

PKCδ translocationTroponin IPhospho-PKCδ (Ser643)

Beyond the preview

Go deeper on Protein kinase C delta (PKCδ) – Receptor for activated C kinase (RACK) interface (PKCδ-RACK interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein kinase C delta (PKCδ) – Receptor for activated C kinase (RACK) interface (PKCδ-RACK interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call